World Biosimilar Congress – brochure ready to download

World Biosimilars Congress 2012, taking place in London from 11-12th September is Europe’s most innovative drug development and Biosimilars conference, where you will find out how to successfully take a biosimilar drug to market (developed and developing) by examining global regulatory pathways and best-practice development and manufacturing protocols.

Download the brochure to see how your peers are achieving commercial success

Attend the World Biosimilars Congress 2012 and  learn how to:

  • Compare regulatory pathways in developed and developing markets, with insight from senior regulatory executives from Amgen, Biogen Idec and Glenmark Pharmaceuticals
  • Get critical insight on global to-market models from Teva’s Chief Clinical Officer, and from the chief executive of newly formed Fujifilm Kyowa Kirin Biologics
  • Debate the minimum level of testing required for a safe and approvable product
  • Consider the best options for product selection based on market analysis
  • Understand how to demonstrate biosimilarity with comparability to the reference product – with critical insight from the US National Institute of Standards and Technology
  • Ensure that immunogenicity standards are kept seamless from development to in-clinic, and find out how to test for and control unwanted immunogenicity with a special presentation from the UK National Institute of Biological Standards and Control

Download the brochure for speakers and programme details or visit the website:

Related news:

Biosimilars set to save big bucks by 2020 – read more

Leave a Reply

Your email address will not be published. Required fields are marked *